Literature DB >> 20542470

Airway luminal T cells: a newcomer on the stage of TB vaccination strategies.

Mangalakumari Jeyanathan1, Armando Heriazon, Zhou Xing.   

Abstract

Protection against pulmonary tuberculosis (TB) by vaccination is often ascribed to the presence of TB-reactive T cells in the lung before infection. Challenging this view, new studies analyzing vaccine-induced T cells in various tissue compartments after parenteral immunization suggest a poor correlation between the presence of anti-TB T cells in the lung interstitium and spleen before Mycobacterium tuberculosis exposure and protection. In contrast, respiratory mucosal immunization leads to distribution of T cells not only in the lung interstitium and spleen, but also in the airway lumen, and the presence of these cells correlates well with protection. Furthermore, airway luminal recruitment of parenteral vaccine-induced T cells in peripheral tissues prior to M. tuberculosis challenge restores protection. We propose that understanding the biology of airway luminal T cells holds important implications for developing effective TB vaccination strategies. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542470     DOI: 10.1016/j.it.2010.05.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  29 in total

1.  Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.

Authors:  Chiara Nembrini; Armando Stano; Karen Y Dane; Marie Ballester; André J van der Vlies; Benjamin J Marsland; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

2.  Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Authors:  M Jeyanathan; N Thanthrige-Don; S Afkhami; R Lai; D Damjanovic; A Zganiacz; X Feng; X-D Yao; K L Rosenthal; M Fe Medina; J Gauldie; H C Ertl; Z Xing
Journal:  Mucosal Immunol       Date:  2015-04-15       Impact factor: 7.313

3.  Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells.

Authors:  M Jeyanathan; S McCormick; R Lai; S Afkhami; C R Shaler; C N Horvath; D Damjanovic; A Zganiacz; N Barra; A Ashkar; M Jordana; N Aoki; Z Xing
Journal:  Mucosal Immunol       Date:  2013-10-30       Impact factor: 7.313

4.  Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Authors:  Patricia A Darrah; Diane L Bolton; Andrew A Lackner; Deepak Kaushal; Pyone Pyone Aye; Smriti Mehra; James L Blanchard; Peter J Didier; Chad J Roy; Srinivas S Rao; David A Hokey; Charles A Scanga; Donata R Sizemore; Jerald C Sadoff; Mario Roederer; Robert A Seder
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

5.  Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant.

Authors:  Yan Yue; Wei Xu; Sidong Xiong
Journal:  DNA Cell Biol       Date:  2011-10-11       Impact factor: 3.311

6.  Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.

Authors:  Yushi Yao; Rocky Lai; Sam Afkhami; Siamak Haddadi; Anna Zganiacz; Fatemeh Vahedi; Ali A Ashkar; Charu Kaushic; Mangalakumari Jeyanathan; Zhou Xing
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

Review 7.  Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

Authors:  Kevin B Urdahl
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

Review 8.  Initiation and regulation of T-cell responses in tuberculosis.

Authors:  K B Urdahl; S Shafiani; J D Ernst
Journal:  Mucosal Immunol       Date:  2011-03-30       Impact factor: 7.313

9.  Pulmonary mycobacterial granuloma increased IL-10 production contributes to establishing a symbiotic host-microbe microenvironment.

Authors:  Christopher R Shaler; Kapilan Kugathasan; Sarah McCormick; Daniela Damjanovic; Carly Horvath; Cherrie-Lee Small; Mangalakumari Jeyanathan; Xiao Chen; Ping-Chang Yang; Zhou Xing
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

10.  CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.

Authors:  Lian Ni Lee; Edward O Ronan; Catherine de Lara; Kees L M C Franken; Tom H M Ottenhoff; Elma Z Tchilian; Peter C L Beverley
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.